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Multi-modal imagingNeuromyelitis optica (NMO) exhibits substantial similarities to multiple sclerosis (MS) in clinical manifestations
and imaging results and has long been considered a variant of MS. With the advent of a speciﬁc biomarker in
NMO, known as anti-aquaporin 4, this assumption has changed; however, the differential diagnosis remains
challenging and it is still not clear whether a combination of neuroimaging and clinical data could be used to
aid clinical decision-making. Computer-aided diagnosis is a rapidly evolving process that holds great promise
to facilitate objective differential diagnoses of disorders that show similar presentations. In this study, we
aimed to use a powerful method for multi-modal data fusion, known as a multi-kernel learning and performed
automatic diagnosis of subjects. We included 30 patients with NMO, 25 patients with MS and 35 healthy volun-
teers and performed multi-modal imaging with T1-weighted high resolution scans, diffusion tensor imaging
(DTI) and resting-state functional MRI (fMRI). In addition, subjects underwent clinical examinations and cogni-
tive assessments. We included 18 a priori predictors from neuroimaging, clinical and cognitive measures in the
initial model. We used 10-fold cross-validation to learn the importance of each modality, train and ﬁnally test
the model performance. The mean accuracy in differentiating between MS and NMO was 88%, where visible
white matter lesion load, normal appearing whitematter (DTI) and functional connectivity had themost impor-
tant contributions to the ﬁnal classiﬁcation. In a multi-class classiﬁcation problemwe distinguished between all
of 3 groups (MS, NMO and healthy controls) with an average accuracy of 84%. In this classiﬁcation, visible white
matter lesion load, functional connectivity, and cognitive scoreswere the 3most important modalities. Our work
provides preliminary evidence that computational tools can be used to help make an objective differential diag-
nosis of NMO and MS.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Neuromyelitis optica (NMO) is a demyelinating disorder with man-
ifestations similar to those of multiple sclerosis (MS). The two condi-
tions are so similar that NMO has long been considered a variant of
MS rather than a separate disease (Lennon et al., 2004). Anti-enter, Neuroscience Institute,
1, Iran. Tel: +98 21 66348572;
n).
. This is an open access article underaquaporin-4 (AQP4) is an antibody recently discovered in serum sam-
ples that can be used to distinguish MS from NMO (Lennon et al.,
2004). However, differentiating NMO from MS may still pose difﬁcult
challenges for clinical decision-making (Jarius and Wildemann, 2010;
Wingerchuk et al., 2006) because an ideal anti-AQP4 assay requires
the newer techniques (e.g., cell-based) and samples from a patient
over time rather than a single serum sample drawn during an NMO
clinical attack (Jarius and Wildemann, 2010). Thus, a subset of
patients remains seronegative. Consequently, recent efforts have fo-
cused on better characterizing the differential features of NMO (Sato
et al., 2014).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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ing (MRI) and computational tools, which are drawing increasing inter-
est among other candidate biomarkers. Potential imaging biomarkers
might include lesion morphology in ultra-high ﬁeld MRI (Sinnecker
et al., 2012), gray matter damage (Calabrese et al., 2012; Rocca et al.,
2004), normal-appearing white matter (Pichiecchio et al., 2012), and
resting-state functionalMRI (fMRI) (Liu et al., 2011).Moreover, another
distinguishing feature could be cognitive functioning, which is affected
in both MS and NMO by various underlying pathomechanisms
(Calabrese et al., 2012; Saji et al., 2013). However, previous studies
have focused on a limited set of measures, and a uniﬁed model that
combines imaging, cognitive and clinical data is still lacking. Similar au-
tomatic diagnostic models have been successfully used to evaluate
Alzheimer3s disease and traumatic brain injury (Klöppel et al., 2008;
Lui et al., 2014), and it would be interesting to apply them to patients
with two similar demyelinating disorders.
Although information frommultiple sources has a great promise for
application in clinical settings, their interpretation is not easy. A
new method that has addressed this problem is multiple-kernel learn-
ing (Sonnenburg et al., 2006; Zhang et al., 2011). Kernels provide func-
tions that transform data into another mathematical space in which
separation of subjects may be easier, and when they are combined,
weights associated with each kernel could also be learned. This ap-
proach provides an intuitive interpretation for the importance of each
source of information (Sonnenburg et al., 2006). So far previous works
in MS have used single kernel methods (Bendfeldt et al., 2012;
Hackmack et al., 2012; Weygandt et al., 2011) on a limited number of
MRI modalities.
Here, we aimed to develop a unifying model that incorporates clini-
cal, imaging and cognitive measures to predict the diagnosis of each
subject. First, we selected a priorimeasures that are potentially affected
during MS or NMO (Table 1). Next, we used a multi-kernel classiﬁer to
investigate the importance of eachmodality and calculated the accuracy
of discrimination between MS and NMO with cross-validation. We hy-
pothesized that multi-modal classiﬁcation would achieve high accuracy
in differentiating MS from NMO. To further validate our approach, we
implemented the same procedure to differentiate patients with each
of these disorders from healthy controls, and in a multi-class classiﬁca-
tion problem, we differentiated between all three groups of patients
with MS, NMO and healthy controls.
2. Materials and methods
2.1. Settings and participants
A total of 35 healthy controls, 30 patients with NMO, and 25 patients
with relapsing–remitting MS were included in this study (Weier et al.,
2014). All patients were recruited at SinaMS Research Center, Sina Hos-
pital, Tehran, Iran between 2009 and 2012. We included patients based
on previously acknowledged criteria: MS diagnosis according to the
McDonald criteria, which were revised in 2005 (Polman et al., 2005),
and NMO diagnosis according to Wingerchuk3s criteria, which were re-
vised in 2006 (Wingerchuk et al., 2006). Exclusion criteria included
(1) clinical attacks within 6 weeks of study initiation, (2) IV methyl-
prednisolone administration during the prior 6 weeks, (3) pregnancy
and (4) neurological or psychiatric disorders other than MS or NMO.
Among the 30 patients with NMO, 56% (17/30) were positive for anti-
aquaporin-4 using indirect immunoﬂuorescence (reference laboratory:
http://www.bioscientia.de, Ingelheim, Germany), whereas all patients
withMSwere negative. Healthy controls, patients withMS and patients
with NMO were matched according to age, gender, and educational
level. All patients underwent a full neurological assessment and were
scored on the Expanded Disability Status Scale (EDSS) (Wingerchuk
et al., 2006) in addition to the 9-hole peg and 25-foot walk tests
(Cohen et al., 2001). All subjects signed written consent forms in accor-
dance with the Declaration of Helsinki (WMA, 2000). The studyprotocol was approved by the Ethical Committee at Tehran University
of Medical Sciences.
2.2. Cognitive assessment
A neuropsychologist assessed all subjects according to our standard
protocol (Eshaghi et al., 2012). Based on our previous study, we chose
the two most sensitive cognitive tests identiﬁed in Iranian MS patients,
namely the Symbol Digit Modality Test (SDMT) and the California Ver-
bal Learning Test version 2 (CVLT-II) (Eshaghi et al., 2012). Test admin-
istration and scoring are described in Table 1. All subjects underwent
cognitive assessment 1week prior toMRI scanning. Noneof thepatients
experienced any clinical relapses during this period.
2.3. MRI protocol
Scanning was performed using a 3 T Siemens Trio scanner
(Erlangen, Germany) with a standard 12-channel head coil. A
unique protocol was used for all participants that included axial FLAIR
(TR/TE = 9000/93 ms, slice thickness = 3 mm, FOV = 220 mm, TI =
2500 ms), axial T2 (TR/TE = 4000/91 ms, slice thickness = 3 mm, 42
slices), 3D magnetization-prepared rapid acquisition with gradient
echo (3D-MPRAGE, TR/TE = 2530/3.44 ms, 1 mm isotropic voxel size,
TI = 1100 ms, FOV = 256 mm), and axial DTI (single-shot diffusion-
weighted EPI, b = 1000 s, 30 directions with 2 averages, TR/TE =
12,000/90 ms, 1.7 × 1.7 × 2 mm voxel size, 68 slices with no gap, 4
diffusion runs without diffusion weighting (b = 0/s)). Functional
MRI images were obtained during a resting state for 7.5 min using a
T2*-weighted EPI sequence with whole-brain coverage (TR/TE =
2200/30 ms, 40 interleaved slices with thickness = 3 mm and no gap,
voxel size isotropic 3 mm with 200 volumes). During fMRI acquisition,
subjects were asked to keep their eyes closed and to avoid thinking of
anything in particular.
2.4. Image analysis
Weused a hypothesis-based approach to select certainmeasures that
are known to be affected byMS or NMO,which are shown in Table 1. Ac-
cordingly, we calculated the following measures from the MRI data:
1) average cortical thickness in regions deﬁned according to the
Desikan–Killiany atlas (Desikanet al., 2006) (T1-weighted images), 2) av-
erage of deep gray matter nuclei volumes (T1-weighted images), 3) T1
hypointense lesion load 4) T2/FLAIR lesion volume, 5) corticospinal
tract fractional anisotropy (FA) (DTI), 6) optic radiation FA (DTI), 7) cor-
pus callosum FA (DTI), 8) sensorimotor network connectivity (fMRI),
9) default mode network connectivity (fMRI), 10) visual network con-
nectivity (fMRI), and 11) cross-sectional upper cervical cord area (T1).
Evidence supporting the selection of eachmeasure is provided in Table 1.
2.4.1. Lesion segmentation: visible white matter lesions
We segmented hyperintense lesions on FLAIR sequenceswith the le-
sion segmentation toolbox in SPM8 (Schmidt et al., 2012). Lesion binary
maps were then manually veriﬁed using T2-weighted images and
edited. We then used the ﬁnal white matter (WM) binary lesion maps
to calculate the lesion load and ﬁll hypointense lesions in T1 -weighted
images with the mean intensity of normal-appearing white matter
(Popescu et al., 2014). Separately, we manually segmented T1
hypointense lesions on the unprocessed T1-weighted images using
Jim software and calculated the lesion volume for each subject.
2.4.2. Cortical thickness analysis
We analyzed the cortical thickness and subcortical volumes of
lesion-ﬁlled 3D-MPRAGE images using FreeSurfer 5.10 as described by
Fischl et al. (Dale et al., 1999). The ﬁnal results were manually con-
ﬁrmed for each subject, then the pipeline was performed again in 22
subjects to achieve satisfactory segmentation. The average thickness of
Table 1
Measures that were used a priori to construct disease prediction models.
Measures (predictors) and
modalities
Description Previous evidence in MS Previous evidence in NMO Method used for calculation
Modality: gray matter
Cortical thickness Average of cortical thickness (in
millimeters) from cortical
regions in the Desikan-Killiany
atlasa.
Gray matter is affected from
the early stages by
demyelination, axonal loss and
neuronal degenerationb.
Gray matter is affected to a
much lesser extent than in MS.
Damage is secondary to
astrocyte loss with less
demyelinationc.
FreeSurfer software: thickness
between white matter surface
and pial surface.
Deep gray matter (DGM) Average volumes of the
thalamus, pallidum, caudate and
globus pallidus (in cubic
millimeters, both hemispheres).
DGM nuclei (speciﬁcally the
thalamus) are affected from
the early stages. Damage may
be secondary to axonal loss in
other regions or primarily due
to iron accumulation or
demyelinationb.
Nuclei are also affected,
possibly to a lesser extent than
in MSc.
Volumetric pipeline of
subcortical segmentation in
FreeSurfer.
Modality: visible WM lesions
T2/FLAIR lesion load Average of visible white matter
lesion volume (cubic
millimeters).
Visible lesions are the basis for
a diagnosis of MS.
A pattern that is distinct from
that of MS in the
hypothalamus and brain stem,
or sometimes a pattern similar
to that observed in MSd.
Jim software and SPM8:FLAIR
lesion mask was calculated
automatically (see text). Next,
it was manually edited while
comparing to T2 images.
T1 lesion load Average of hypointense lesion
volume (cubic millimeters).
T1 hypointense lesions could
be better correlated with
disability than T2 lesionse.
Could be seen in destructive
lesionf.
Jim software: Hypointense
lesions were manually marked
and segmented by an expert
neurologist
Modality: DTI
Corpus callosum fractional
anisotropy (normal-appearing
white matter only)
Average of fractional anisotropy
(FA) along the corticospinal
tract, localized according to the
Jülich histological atlas after
exclusion of the visible lesion
mask (Fig. 1D).
A hallmark of MS; decreased
white matter integrity is easily
detectable in this areag.
May be affected secondary to
non-speciﬁc white matter
lesionsg.
FSL software: binary mask of
the corpus callosum was
warped to the subjects3 native
space; the visible white matter
lesion mask was subtracted;
and the mean average of FA
was calculated.
Corticospinal tract FA
(normal-appearing white
matter only)
Average of FA along the
corticospinal tract, localized
according to the Jülich
histological atlas after exclusion
of the visible lesion mask
(Fig. 1D).
Presents a loss of integrity,
which is associated with
disability and clinical
progressionh.
May present damage
secondary to myelitisi.
FSL software: as described
above, except with the
corticospinal binary mask
(bilateral).
Optic radiation
(normal-appearing white
matter only)
Average of FA along the bilateral
optic radiation tract (reference
atlas: Jülich histological atlas)
after exclusion of the visible
lesion mask (Fig. 1D).
Damaged in MS, secondary to
trans-synaptic degeneration in
the optic nerve and Wallerian
degeneration due to local
lesionsg.
DTI studies have revealed a
loss of integrity in patients
with NMO with distinct
pathogenic processes
compared with those of MSh.
FSL software: as described
above.
Modality: fMRI
Sensorimotor network
connectivity
Average of Z-scores in the net-
work identiﬁed using group in-
dependent component analysis
(ICA) in healthy controls
(Fig. 1B).
Presents aberrant connectivity,
which may be due to
compensatory mechanisms or
maladaptive plasticityi.
Only a handful of studies are
available; may show aberrant
connectivityj.
FSL software: independent
components analysis (ICA)
separates signals into
underlying sources. Next, a
dual-regression approach was
used to extract functional
connectivity values (Z-scores).
Default mode network
connectivity
Average of Z-scores in the net-
work identiﬁed using group ICA
in healthy controls (Fig. 1C).
Presents abnormal
connectivity even in patients
with clinically isolated
syndrome and is known to be
affected in other neurological
or psychiatric disordersi.
A few studies have shown
changes compared to healthy
controlsj.
FSL software: the same
method used for the
sensorimotor network.
Visual network Average of Z-scores in the visual
network identiﬁed using group
ICA.
Visual network supports a
“basic” function and failed to
show any change in a previous
study, it will be used here as a
control networki.
– Same method used for
previous two networks.
Upper cervical cord
cross-sectional area
Average cross-sectional area
from foramen magnum to C2.
Presents volume loss and is
associated with disabilityg.
Primarily affected during
NMO.
Jim software: semiautomatic
reconstruction of the spinal
cord, followed by calculation
of the average cross-sectional
area (square millimeters).
Modality: clinical scores
EDSS EDSS score, assessed by the
neurologist providing care.
Used as an outcome measure
in MS clinical trials.
Originally developed for MS,
but also applied to NMO.
Neurological examination
(ranging from 0–10).
9-Hole peg test Part of the multiple sclerosis
functional composite (MSFC).
Tests upper motor disability and
cerebellar functions.
Associated with motor
performance and cerebellar
coordination.
Could be more impaired in
NMO due to more devastating
attacks.
Average of two trials with
dominant and non-dominant
hand in seconds.
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Table 1 (continued)
Measures (predictors) and
modalities
Description Previous evidence in MS Previous evidence in NMO Method used for calculation
25-Foot walk test Part of the multiple sclerosis
functional composite (MSFC).
Associated with motor
performance and cerebellar
coordination.
Could be impaired in NMO
secondary to more severe
attacks.
Average of two trials in which
patients walk a 25-foot
distance as quickly as possible,
measured in seconds.
Low-contrast (2.5%) visual test Sloan low-contrast letter acuity
is a standardized measure
suggested in addition to the
MSFC.
This test has been extensively
validated in MS trials and
speciﬁcally relates to optic
neuritis and general optic
nerve damage in MSk.
Validated in NMO and
associated with retinal axonal
and neuronal lossk.
Binocular testing: the total
number of correct letters was
counted and reported.
Modality: cognitive scores
Symbol Digit Modality Test
(SDMT)
Evaluates information
processing and working
memory domains: 10 abstract
symbols are paired with
numbers ranging from 1 to 10.
The subject is given 90 s to pair
new symbols with the correct
number.
The most sensitive test able to
detect cognitive impairment
associated with MS in the
Iranian populationl.
Also affected in NMO due to
cortical degenerationm.
Neuropsychological battery
administered by a
neuropsychologist: the total
number of symbols correctly
paired with the corresponding
numbers in 90 sl.
California Verbal Learning Test
(CVLT) version 2
Evaluates short- and long-term
verbal memory: a list of 10
words that are read to the
subject 5 times; the subject then
recalls the words, and the
response is recorded. After
20 min, the subject is asked to
recall the words.
The second most sensitive
cognitive test in the Iranian
population and used to detect
MS-related cognitive
weaknessl.
Verbal memory is also affected
in NMOm.
Neuropsychological battery
administered by a
neuropsychologist: the total
number of correct words over
the ﬁrst 5 trials is deﬁned as
the “total learning score.” The
total number of recalled words
after 20 min is deﬁned as the
“delayed recall score.”
a Dale et al. (1999).
b Geurts et al. (2012).
c Popescu et al. (2010).
d Kim et al. (2012).
e Giorgio et al. (2014).
f Filippi et al. (1999).
g Wegner (2013).
h von Glehn et al. (2014).
i Roosendaal et al. (2010).
j Liu et al. (2011).
k Balcer and Frohman (2010).
l Eshaghi et al. (2012).
m Saji et al. (2013).
Fig. 1. (A, B and C) show selected independent component analysis maps from resting-state networks of healthy controls that correspond to the (A) visual, (B) sensorimotor, and
(C) default mode networks. (D) shows Jülich histological probability masks of (from left to right) the corpus callosum, optic radiation and corticospinal tracts.
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date nucleus, putamen and globus pallidus were calculated for each
subject.
2.4.3. DTI analysis: normal-appearing WM
We used FSL 4.1.9 to post-process diffusion-weighted volumes.
Diffusion-weighted images were registered to the image without diffu-
sionweighting (b0) using afﬁne transformations tominimize distortion
due to motion and eddy currents and then brain-extracted using the
Brain Extraction Tool (BET) (Smith, 2002). Fractional anisotropy (FA)
images were generated using FMRIB3s diffusion toolbox (FDT). We
non-linearly aligned all FA images with the FMRIB58 template as the
common registration target. The corpus callosum, bilateral optic radia-
tions, and corticospinal tracts were masked in the common template
using the Jülich probabilistic histological atlas in FSL (Toga et al.,
2006), and these binary masks were inverse-warped to each subject3s
native space (Fig. 1). Next, we subtracted the visible WM lesion masks
acquired from the lesion segmentation step above, from the ROI deﬁned
by the atlas. Accordingly, only normal-appearing WM voxels remained
in the pathway of each deﬁned tract. Finally, the FA average of each
mask was extracted for all subjects.
2.4.4. Resting-state fMRI analysis
We employed a group independent component analysis and a dual
regression approach to study functional network connectivity in MS
and NMO patients and in healthy subjects using FSL (Beckmann et al.,
2005; Filippini et al., 2009). The pre-statistics processing of fMRI images
consisted of removing the ﬁrst 5 volumes from each time-series, brain
extraction, motion correction, slice timing correction for interleaved ac-
quisition, high-pass ﬁltering with a frequency cut-off of 100 s, spatial
smoothing using a Gaussian kernel of full-width at half-maximum
(5mm), and transformation to anMNI-152 standard template. To iden-
tify resting-state networks, we performed independent component
analysis on scans acquired fromhealthy controlswith automatic dimen-
sionality estimation, which revealed 53 spatio-temporal components
(Beckmann et al., 2009). Of these, we selected 3 components (the de-
fault mode, sensorimotor and visual networks, see below for maxima
coordinates) based on cross-correlation with a previous meta-
analytical template of resting-state networks (available online at
http://www.fmrib.ox.ac.uk/analysis/brainmap+rsns/) and visual neu-
roanatomical correspondence (Smith et al., 2009) (Fig. 1A, B and C).
Next, we used a dual regression approach for all subjects (both pa-
tients and controls) to identify spatial maps and corresponding
timecourses for each component. At the ﬁrst stage, group-level spatial
maps were used as a set of spatial regressors to determine the temporal
dynamics of the components at the subject level. Next, these
timecourses were variance-normalized to allow comparison of the
shape and amplitude of resting-state networks. At the second stage,
the timecourses were used as temporal regressors to determine spatial
maps at the subject level. Finally, a region-of-interest analysis was per-
formed on the resulting maps to extract the functional connectivity
from each subject. For this step, we used reference network coordinates
from the referencemaps. The peak of the independent component anal-
ysis calculated on healthy subjects for the default mode (X = −0.2,
Y = −55.4, Z = 14.5, in mm, MNI space), sensorimotor (right: X =
33.4, Y=−16.3, Z=53.7; left: X=−29.6, Y=−17.8, Z=57) and vi-
sual networks (X=0.9, Y=−93.8, Z= –4)was used to deﬁne the cen-
ter of a 10-mm spherical mask in MNI152 space. The mean functional
connectivity values (z-scores) with respective resting-state networks
were calculated for each subject.
2.4.5. Upper cord cross-sectional area calculation
We used a semi-automatic method in the Jim software to calculate
the average cord cross-sectional area from the foramen-magnum to
C2 on 3D-MPRAGE scans as described elsewhere (Horsﬁeld et al., 2010).2.5. Statistical analysis
2.5.1. Descriptive statistics
The mean age, disease duration, and years of education along with
themedian and range of the EDSS score were calculated.We also calcu-
lated the correlation coefﬁcient among each pair of measures.
2.5.2. Predictive modeling: training and cross-validation
We used the Caret package inside R version 3.1.1 (Kuhn and
Johnson, 2013) and the Shogun toolbox version 3.2.0 inside C++. We
included all 18 variables (Table 1) in a support vector machine (SVM).
The SVM is a standard model to investigate variables with binary
(e.g., MS and NMO) or multi-class outcomes (e.g., MS, HCs and NMO)
(Guyon et al., 2002; Klöppel et al., 2012). The SVM is a kernel-based
method, has been extensively validated as a diagnosticmodel for neuro-
imaging (Klöppel et al., 2008; Stonnington et al., 2010), and can handle
heterogenous data frommultiple sources with a combination of kernels
(Sonnenburg et al., 2006). Similar to Zhang et al. (2011)we use one ker-
nel for each modality, combine them, learn each kernel3s weight during
training, and ﬁnally classify patients in the test set. Modality is referred
to each source of information, that is one for clinical scores, one for cog-
nitive scores, and 5 for imaging (Fig. 2).
We distinguished between groups with two approaches: 1) binary
classiﬁcation with 3 different models: NMO vs MS, healthy control
(HC) vs MS, and HC vs NMO, and 2) multi-class classiﬁcation (one-vs-
rest method): we distinguished between MS and both patients with
NMO or HCs using multiple one-vs-rest models (Rifkin and Klautau,
2004). When comparing patients to HCs, we excluded measures that
were unavailable for healthy volunteers (EDSS and low-contrast test
score). Ten-fold cross validation was used to partition data into 10
chunks, each of which were used once for testing and the remaining 9
were used to train the classiﬁers and to calculate the kernel weights.
We report the average accuracy of the classiﬁer over 10 folds. For sim-
plicity and ease of interpretation, we used linear kernels in all SVMs in
this study, except for multi-class classiﬁcation where we used polyno-
mial and Gaussian kernels.
3. Results
3.1. Clinical and demographic characteristics
The mean age of patients with NMO was 33.58 years, with a mean
disease duration of 6.07 years and a median EDSS score of 3 (detailed
demographic measures are shown in Table 2). The disease-modifying
drugs used by patients with NMO consisted of the following: azathio-
prine in 18 patients, mycophenolatemofetil in 5 patients, mitoxantrone
in 1 patient, cyclophosphamide in 1 patient, methotrexate in 1 patient
and oral prednisolone in 1 patient; the remaining patients did not re-
ceive any medications. Patients with MS received the following
disease-modifying drugs: 17 patients received β-interferon, 2 received
azathioprine and 1 received mitoxantrone; the remaining patients did
not receive medication.
3.2. Descriptive statistics
Fig. 3 shows the median and 75th percentile of the imaging (A) and
clinical (B) predictors in boxplots. Fig. 4 shows the correlation maps
among all variables.
3.3. Importance of each modality and prediction of diagnosis
3.3.1. MS and NMO
Mean accuracy of this model was 88 % with a standard deviation
(SD) of 11. The important modalities (Fig. 2 and Table 3) according to
their kernel weights were: 1) visible WM lesion load, 2) DTI, 3) fMRI,
4) cognitive scores, 5) gray matter measures, 6) spinal cord area, and
7) clinical scores. Among patients with seronegative NMO, 83% and
Fig. 2. Diagram of multimodal data fusion, learning kernel weights and cross-validation.
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test sets (p N 0.05 for equality of proportions). When only using the
most importantmodality (visibleWM lesion load) the average accuracy
was 74%.3.3.2. MS and HC
The mean accuracy was 91% with an SD of 8. Important modalities
were: 1) visible WM lesion load, 2) DTI, 3) clinical scores, 4) fMRI,
5) cognitive scores, 6) gray matter measures, and 7) spinal cord area.
When only using the most important modality, the average accuracy
was 76%.3.3.3. NMO and HC
The mean accuracy was 78% with an SD of 12. Important modalities
were: 1) clinical scores, 2) cognitive scores, 3) fMRI, 4) DTI, 5) graymat-
ter measures, 6) spinal cord area, and 7) visible WM lesion load. When
using only themost importantmodality (clinical scores) the average ac-
curacy was 71%.3.3.4. Multi-class classiﬁcation: classiﬁcation of MS, NMO and HCs in a sin-
gle model
The mean accuracy (±SD) was 84% with an SD of 8. Important mo-
dalities formulti-label classiﬁcationwere: 1) visibleWM lesions 2) fMRI
3) cognitive scores 4) DTI. Other modalities received 0 weights in the
combined kernel. When using the most important modality (visible
WM lesion load) the average accuracy was 74%.Table 2
Demographic characteristics.
Measures Groups
HCa NMOb MSc
Mean age ± SD 31.94 ± 9.07 33.58 ± 10.1 32.85 ± 8.49
Mean disease duration ± SD – 6.07 ± 3.29 8.04 ± 7.04
Gender ratio (female:male) 31:4 26:4 22:3
Mean years of education ± SD 13.4 ± 2.92 12.41 ± 3.58 12.96 ± 3.56
a Healthy control.
b Neuromyelitis optica.
c Multiple sclerosis.4. Discussion
Themain purpose of this studywas to integrate clinical, imaging and
cognitive measures to automatically distinguish patients with MS from
those with NMO.
We combined kernels to unify heterogenous data from multiple
sources, and to distinguish MS from NMO. We further extended our
model to multi-class algorithms, where we classiﬁed MS, NMO and
HCs in a single model with a high accuracy (84%). When looking at
each pair of groups, the accuracy of the model was 88% to distinguish
MS and NMO patients, 91% between HCs and patients with MS,
and 78% between HCs and patients with NMO. The most important
modalities, according to their kernel weights, revealed that when
distinguishing the NMO andMS groups differential changes weremost-
ly found in WM measures (visible WM lesion load and normal
appearing white matter integrity), followed by the resting-state fMRI
connectivity and cognitive functioning. To the best of our knowledge
this is the ﬁrst study to classify two similar demyelinating disorders
with multi-modal data fusion.
There is an increasing interest in the neuroimaging community to
use computational and diagnostic models. They have been previously
used to evaluate Alzheimer3s disease, traumatic brain injury, and stroke,
showing performance that is comparable to that of human experts
(Klöppel et al., 2008; Lui et al., 2014; Thompson et al., 2014; Zhang
et al., 2011). Our study gives preliminary evidence for the utility of com-
putational tools in differentiating MS and NMO, the results of which
could have important implications for developing future clinical
decision-making algorithms.
Multivariate data-fusion methods can identify complex patterns of
neuroanatomical changes (Sui et al., 2014). When distinguishing be-
tween the NMO and MS groups, the visible WM lesion load (T1 and T2
lesion load) and normal-appearing WM integrity (DTI) were the most
important features, showing a consistent damage in the MS group
among different measures. The next important modality was resting-
state functional connectivity, which consisted of connectivities of
default-mode, sensorimotor and visual networks.When looking at indi-
vidual measures in Fig. 3A, the sensorimotor and default-mode net-
works show more variability between groups than the visual network.
The visual network is responsible for a “basic” function that is not ex-
pected to differ between groups, which increases our conﬁdence that
Fig. 3. Boxplots show the median and 75th percentile for each variable extracted from (A) imaging or (B) clinical and cognitive assessments. Functional connectivity values are normalized (mean = 0, and SD = 1.5).
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Fig. 4. Between predictor correlations for imaging, cognitive and clinical parameters in pa-
tients. Each rowand column represent a predictor (Table 1), and each rectangle represents
the correlation coefﬁcient between the corresponding variables on the x and y axes.
313A. Eshaghi et al. / NeuroImage: Clinical 7 (2015) 306–314the differences between other networks are meaningful, as was shown
in a previous study (Roosendaal et al., 2010). We observed a consistent
damage in WM and GM in patients with MS in comparison with the
NMOpatients and HCs. In patients with NMO, this coincidedwith an in-
creased sensorimotor network connectivity andmay indicate that more
subtlemotor system damage in the brains of patients with NMO is asso-
ciatedwith an increased connectivity in the sensorimotor network, pos-
sibly due to compensatory effects (Fig. 3A) (Pantano et al., 2002).
Interestingly, when comparing DMN connectivity in each group of pa-
tientswith that of healthy controls, a subtle decrease in DMNconnectiv-
ity in NMO but not MS patients was associated with sustained cognitive
functioning (Fig. 3A and Fig. 4). This ﬁnding is consistent with previous
studies, indicating the role of DMN suppression in supporting externally
oriented cognitive functioning (Anticevic et al., 2012). These ﬁndings
show thatmultivariate pattern classiﬁcation using an SVM can integrate
complex brain changes to support clinical diagnoses.
Multi-class classiﬁcation better reﬂects a dilemma in routine clinical
practice, when more than one differential diagnosis are considered
(Klöppel et al., 2012). Our model reached excellent accuracy (84%) to
distinguish between all three groups. Visible WM lesions, fMRI, cogni-
tive scores and DTI received high weights while other modalities re-
ceived 0 weights. A classiﬁcation based on only visible white matter
lesions showed an accuracy of 74%, which highlights the importance
of more advanced modalities in difﬁcult classiﬁcation problems. FutureTable 3
Importance ranking of signiﬁcant modalities.
Binary classiﬁcation
Modality rank MS vs NMO
(relative kernel weight)a
MS vs HC
(relative kernel weight)
1 Visible WM lesion load (0.20) Visible WM lesion load (0.4
2 DTI (0.18) DTI (0.16)
3 fMRI (0.17) Clinical scores (0.13)
4 Cognitive scores (0.16) fMRI (0.10)
5 Gray matter measures (0.15) Cognitive scores (0.08)
6 Spinal cord area (0.06) Gray matter measures (0.0
7 Clinical scores (0.08) Spinal cord area (0.004)
a Multi-kernel learning combines different kernels and gives each of them a weight. Linear c
relative weight is deﬁned as the normalized weight that is given to each kernel, and is averagestudies should include other common differential diagnoses of MS, such
as CNS vasculitis in a multi-class classiﬁcation problem.
It is also important to acknowledge several limitations of our study.
First, this is a single-center classiﬁcation study that can only provide
preliminary results and does not ensure between-cohort generalization.
Future studies will incorporate our data with data from other centers to
evaluate the robustness of the model. Second, we found similar perfor-
mance in distinguishing seronegative and seropositive NMO patients
(83% vs 88%) from patients with MS, however, an ideal situation
would be to recruit enough patients to train amodel on seropositive pa-
tients with NMO and then test new patients with seronegative NMO,
the results of which could support the clinical diagnosis when the
serum assay remains negative. The third limitation is that our gold stan-
dard for classiﬁcation remains a diagnosis made by an expert neurolo-
gist based on the acknowledged criteria, and we could not exclude the
possibility of mislabeling due to imperfect diagnostic criteria for MS
andNMO.Without solving this issue, perfect classiﬁcation is impossible.
This limitation might be overcome by longer follow-up of patients and
employing frequent diagnostic procedures (e.g., multiple serum sam-
ples for anti-aquaporin-4 over time).
In conclusion, our workﬂow produces accurate models for differen-
tiating patients with NMO from thosewithMS and from healthy volun-
teers. The combination of imaging with clinical and cognitive measures
provides further improvement of the accuracy and could disentangle
complex changes across several modalities. This work provides proof-
of-concept evidence for the premise of computational models that aid
in the objective differential diagnosis of MS and NMO. In future, multi-
modal data-fusion could be used to predict disability outcomes in MS
using a similar method to this work.
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